Synthesis, structural analysis and antibacterial activity of a butyl ester derivative of ampicillin

被引:12
作者
Bartzatt, R
Malesa, C
机构
[1] Univ Nebraska, Coll Arts & Sci, Dept Chem, Durham Sci Ctr, Omaha, NE 68182 USA
[2] Univ Nebraska, Coll Arts & Sci, Dept Biol, Omaha, NE 68182 USA
关键词
ampicillin; Escherichia coli; diazobutane;
D O I
10.1159/000072444
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Ester groups placed on medicinal agents have been found to increase lipophilicity (more positive log p value). Alterations in a partition coefficient may affect medicinal activity. Formation of an ester group such as -C(O)OCH2CH2CH2CH3 from a carboxyl group [-C(O)OH]can be efficiently accomplished utilizing diazo-alkanes and produces a prodrug-like structure of ampicillin (a bipartate drug carrier). Formation of an ester group may produce beneficial changes in medicinal parameters such as log P, log BB, and molecular polar surface area (TPSA). Methods:An ester of ampicillin was synthesized by replacing the carboxyl group with a butyl ester group. The ester formed was synthesized utilizing diazo-butane, which is a gas at room temperature and reacts with the acidic hydrogen of the carboxylic acid. The ampicillin ester was dissolved into LB agarose media at levels of 0.228 and 0.180 mg/ml, and its antibacterial activity was compared to that of normal ampicillin. Medicinal parameters such as log P, solubility, polar surface area, log BB, molecular dipole, Clog P, intestinal absorption and the 'Rule of 5' were determined. Results: The ampicillin ester consisted of yellow crystals that were table for >12 weeks at 0degreesC. The ester has reduced hydrogen bonding capacity and increased lipophilic character (by log P) compared to the parent structure. Each concentration of the ester tested induced 100% growth inhibition of ampicillin-susceptible but streptomycin-resistant Escherichia coli bacteria, and >30% growth inhibition of an ampicillin-resistant E coli. This ester compound of ampicillin showed zero violations of the 'Rule of 5', which indicates good bioavailability and good bioactivity. Intestinal absorption indicated by TPSA value showed moderate absorption activity for both parent and ester compounds. The lipophilic substituent constant for the butyl ester is +0.941, which indicates increased lipophilicity. The ester group improves log BB and dermal permeability of ampicillin. Conclusion: The butyl ester of ampicillin inhibited the growth of susceptible and resistant E coli. Favorable values for parameters such as TPSA, log P, log BB, and zero violations of the 'Rule of 5' suggest good bioavailability and good bioactivity. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 17 条
[1]   Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan [J].
Ahmed, AA ;
Osman, H ;
Mansour, AM ;
Musa, HA ;
Ahmed, AB ;
Karrar, Z ;
Hassan, HS .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2000, 63 (5-6) :259-263
[2]  
BROCK TD, 1991, BIOL MICROORGANISMS, P121
[3]  
DAVIS BD, 1990, MICROBIOLOGY, P78
[4]  
GOODMAN LS, 1970, PHARMACOL BASIS THER, P15
[5]   Oxacillin-resistant phenotypes of Staphylococcus aureus [J].
Haberberger, RL ;
Kallen, AJ ;
Driscoll, TJ ;
Wallace, MR .
LABORATORY MEDICINE, 1998, 29 (05) :302-305
[6]   Ampicillin-resistant Escherichia coli in gestational pyelonephritis:: Increased occurrence and association with the colonization factor Dr adhesin [J].
Hart, A ;
Nowicki, BJ ;
Reisner, B ;
Pawelczyk, E ;
Goluszko, P ;
Urvil, P ;
Anderson, G ;
Nowicki, S .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (10) :1526-1529
[7]  
Iwane T, 2001, WATER SCI TECHNOL, V43, P91
[8]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[9]   Computation of brain-blood partitioning of organic solutes via free energy calculations [J].
Lombardo, F ;
Blake, JF ;
Curatolo, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (24) :4750-4755
[10]  
MORIGUCHI I, 1992, CHEM PHARM BULL, V40, P127